Bookmark Saya

CrossRef Open Access 2025

Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritis

Arjun Mahajan Alessandra Tomasi Matthew A Sparks Maureen Whittelsey Avery LaChance +1 lainnya
Lihat Sumber DOI

Penulis (6)

A

Arjun Mahajan

A

Alessandra Tomasi

M

Matthew A Sparks

M

Maureen Whittelsey

A

Avery LaChance

J

Jeffrey A Sparks

Format Sitasi

APA MLA BibTeX
Mahajan, A., Tomasi, A., Sparks, M.A., Whittelsey, M., LaChance, A., Sparks, J.A. (2025). Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritis. https://doi.org/10.1093/rheumatology/keaf693

Akses Cepat

Lihat di Sumber doi.org/10.1093/rheumatology/keaf693
Informasi Jurnal
Tahun Terbit
2025
Bahasa
en
Sumber Database
CrossRef
DOI
10.1093/rheumatology/keaf693
Akses
Open Access ✓